Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionFisher Asset Management, LLC
Latest Disclosed Ownership122,226 shares
Latest Disclosed Value $ 16,102,051
Fisher Asset Management, LLC reports 8.90% increase in ownership of NBIX / Neurocrine Biosciences, Inc.

On May 5, 2026 - Fisher Asset Management, LLC filed a 13F-HR form disclosing ownership of 122,226 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $16,102,051 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 112,242 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 8.90% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 122,226 9,984 8.90 16,102 1.15 0.0055
2026-02-09 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 112,242 17,447 18.40 15,919 19.63 0.0054
2025-11-12 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 94,795 7,255 8.29 13,307 20.95 0.0048
2025-08-13 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 87,540 -7,717 -8.10 11,003 4.43 0.0044
2025-05-14 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 95,257 3,153 3.42 10,535 -16.20 0.0046
2025-02-05 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 92,104 23,834 34.91 12,572 59.83 0.0050
2024-11-12 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 68,270 4,930 7.78 7,866 -9.79 0.0032
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 63,340 -1,826 -2.80 8,720 -2.97 0.0038
2024-05-09 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 65,166 4,939 8.20 8,988 13.26 0.0042
2024-03-05 2023-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 60,227 -1,600 -2.59 7,936 14.09 0.0042
2024-02-06 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 59,971 -1,856 7,902 0.0039
2023-11-13 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 61,827 -179 -0.29 6,956 18.95 0.0039
2023-12-12 2023-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 62,006 -2,136 -3.33 5,847 -9.94 0.0032
2023-08-08 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 62,006 -2,136 6 0.0032
2023-12-12 2023-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 64,142 -126 -0.20 6,492 92,642.86 0.0039
2023-05-01 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 64,487 219 7 0.0040
2023-02-03 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 64,268 -848 -1.30 8 -99.90 0.0052
2022-11-08 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 65,116 -5,362 -7.61 6,916 0.67 0.0052
2022-08-09 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 70,478 -4,178 -5.60 6,870 -1.84 0.0049
2022-05-05 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 74,656 9 0.01 6,999 10.08 0.0041
2022-02-02 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 74,647 5,453 7.88 6,358 -4.19 0.0036
2021-10-26 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 69,194 7,545 12.24 6,636 10.60 0.0041
2021-07-27 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 61,649 3,473 5.97 6,000 6.04 0.0038
2021-04-27 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 58,176 746 1.30 5,658 2.78 0.0040
2021-01-29 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 57,430 -1,791 -3.02 5,505 -3.34 0.0041
2020-11-12 2020-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 59,221 -4,006 -6.34 5,695 -26.17 0.0050
2020-11-10 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 59,221 -4,006 5,695 4,836.0372
2020-08-07 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 63,227 -1,340 -2.08 7,714 38.05 0.0075
2020-04-28 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 64,567 -2,208 -3.31 5,588 -22.15 0.0069
2020-02-12 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 66,775 -6,252 -8.56 7,178 9.09 0.0073
2019-10-29 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 73,027 -1,393 -1.87 6,580 4.73 0.0072
2019-07-30 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 74,420 47,257 173.98 6,283 162.56 0.0069
2019-04-22 2019-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 27,163 -477 -1.73 2,393 21.23 0.0028
2019-04-22 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 27,640 0 1,974
2019-01-25 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 27,640 -507 -1.80 1,974 -42.96 0.0027
2018-10-23 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 28,147 -3,195 -10.19 3,461 12.41 0.0042
2018-07-09 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 31,342 25,702 455.71 3,079 557.91 0.0040
2018-04-20 2018-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 5,640 615 12.24 468 20.00 0.0006
2018-04-19 2018-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,640 615 468
2018-01-24 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,025 -28 -0.55 390 25.81 0.0005
2017-10-17 2017-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,053 5,053 310 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.